Wasp-Eze

Country: Malta

Language: English

Source: Medicines Authority

Buy It Now

Active ingredient:

BENZOCAINE, MEPYRAMINE MALEATE

Available from:

Seton Products Limited Tubiton House, Medlock Street, Oldham, United Kingdom

ATC code:

D04AB04

INN (International Name):

BENZOCAINE 1 % (W/W) MEPYRAMINE MALEATE 0.5 % (W/W)

Pharmaceutical form:

CUTANEOUS SPRAY

Composition:

BENZOCAINE 1 % (W/W) MEPYRAMINE MALEATE 0.5 % (W/W)

Prescription type:

OTC

Therapeutic area:

ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.

Authorization status:

Withdrawn

Authorization date:

2007-12-10

Patient Information leaflet

                                 
 
 
 
 
 
 
 
 
 
 
 
 
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                 
       Page 1 of 3 
SUMMARY OF PRODUCT CHARACTERISTICS 
 
 
1. 
NAME OF MEDICINAL PRODUCT 
 
Wasp-Eze Spray 
 
2. 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
 
Benzocaine 
1.0% w/w 
Mepyramine maleate  
0.5% w/w 
 
For excipients, see 6.1. 
 
3. PHARMACEUTICAL 
FORM 
 
Aerosol spray. 
 
4. CLINICAL 
PARTICULARS 
 
4.1 THERAPEUTIC 
INDICATIONS 
 
For the treatment of all insect bites and stings, nettle
stings and jellyfish stings. 
 
4.2  POSOLOGY AND METHOD OF ADMINISTRATION 
 
Route of administration 
_ _
Topical. 
 
Adults, the elderly and children: 
 
Hold nozzle approximately five inches from the skin and
spray once for 2-3 seconds. Stop 
spraying immediately if a white deposit or ‘frost’
appears. Repeat once after 15 minutes if 
necessary. If pain persists, seek medical advice. 
 
4.3 CONTRAINDICATIONS 
 
Do not apply to broken skin. 
Do not use near the eyes. 
Do not use if you are sensitive to benzocaine. 
 
4.4  SPECIAL WARNINGS AND PRECAUTIONS FOR USE 
 
Patients with any known allergy should seek medical advice.
If pain persists, seek medical 
advice. 
For external use only. Keep out of the reach of children. 
Flammable. Do not use near fire or flame.
Pressurised container. Protect from sunlight and do 
not expose to temperatures exceeding 50
°C. Do not pierce or burn, even after use.  Do not 
spray on a naked flame or any incandescent material. Do not use
near or place container on 
polished or painted surfaces. 
 
       Page 2 of 3 
 
4.5  INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION 
 
None known. 
 
4.6  PREGNANCY AND LACTATION 
 
No known effects in pregnancy and lactation. However, as with
all medicines, use with 
caution. 
 
4.7  EFFECTS ON ABILITY TO DRIVE AND USE MACHINES 
 
None known. 
 
4.8 UNDESIRABLE 
EFFECTS 
 
Skin rash. 
Methaemoglobinaemia especially in infants and children. 
 
4.9 OVER
                                
                                Read the complete document
                                
                            

Search alerts related to this product

View documents history